Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.24% to 7274.38, DAX +0.34% to 15657.10, CAC40 +0.45% to 7144.08, STOXX 600 +0.17% to 448.40

Jul 10 ,2023

  • Synopsis:

    • European equity markets closed mixed to higher. Greece +1.0%, France, Switzerland +0.5% led the overperformers whilst Denmark (0.7%), Austria (0.4%) and Sweden (0.3%) led the underperformers.

    • In political developments, headlines revolved around Dutch PM Rutte resignation after government collapsed. Rutte will leave politics and will not be available as a VVD party leader in the next parliamentary elections. Also, Swedish PM Kristersson and Turkey's President Erdoğan meeting in attempt to resolve differences and get Turkey's backing for Sweden's NATO membership. Turkey's president has said his country will support Sweden's bid to join NATO if the EU opens membership talks for his country (BBC).

    • Central bank narrative still in focus. Riksbank minutes reiterated hawkish spin after it hiked rates 25-bps to 3.75% on 29-Jun and signalled more tightening to come. Bank of France Governor Villeroy said rates to remain higher when tightening cycle ends. Meanwhile, BoE Governor Bailey reiterated commitment to meeting inflation target on the weekend but said it could lengthen horizon it brings prices back to target. Looking at macroeconomics, Eurozone sentix survey weaker than forecast.

    • In corporate news, Plus500 (PLUS.LN) issued H1 trading update and said FY23 expected to be in line with current market expectations. Further in the UK, Quartix Technologies (QTX.LN) expects FY revenue, adjusted EBITDA, and free cash flow to be in line with consensus market forecasts. Global Ports Holding (GPH.LN) also reported FY earnings.

    • Out of the Nordics, Raisio (RAIVV.FH) lowered FY comparable net sales outlook, specified comparable operating profit guidance. From the Dach region, Evonik Industries (ECK.GR) reported preliminary Q2 adjusted EBITDA €430-450M vs FactSet €468.1Mand lowered FY guidance. APONTIS PHARMA (APPH.GR) announced CEO Karl-Heinz Gast resigns for personal reasons; to be succeeded by Bruno Wohlschlegel.

    • Also in other corporate developments, Novartis (NOVN.SW) will appeal to U.S. Court of Appeals to uphold validity of Entresto combination patent; maintains 2023 guidance and mid-term outlook. Recall Novartis shares fell over 3% on Friday afternoon into the close as reports of the patent ruling hit the tape.

    • On M&A front, Bayer (BAYN.GR) is preparing to spin off CropScience, reports Platow Borse. Torqx Capital Partners intends to acquire Beter Bed Holding (BBED.NA) for of €6.10/share in cash cum dividend. The Telegraph reports that BT (BT.A.LN) is on high alert for a potential takeover by major shareholder Deutsche Telekom (DTE.GR)

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers

        • Travel & Leisure +1.33%, Technology +0.56%, Construct & Mtls +0.45%, Retail +0.41%, Ind Goods & Svcs +0.39%, Oil & Gas +0.39%, Persnl & HHold Goods +0.33%, Food & Beverage +0.20%, Chemicals +0.19%,

      • Underperformers

        • Utilities (0.71%), Real Estate(0.68%), Basic Resources (0.67%), Telecom (0.31%), Banks (0.17%), Autos & Parts (0.03%), Media +0.02%, Financial Svcs +0.10%, Insurance +0.14%, Health Care +0.15%,

    • Macro/Peripheral markets:

      • EU

        • EU Commission adopts new adequacy decision for safe and trusted EU-US data flows - release

        • EU-US data-sharing deal comes into force amid threats of legal challenge - FT

      • UK

        • Somerton and Frome by-election: Lib Dems close polling gap in safe Tory seat with eleven days to go - inews

        • Jeremy Hunt to set out City reforms to drive UK growth and investment - FT

        • UK to Tout £50B for Startups as part of pension reforms - Bloomberg

        • Unite overwhelmingly rejects disaffiliation from the Labour Party - Unite

        • Starmer put 'on notice' by Unite leader after vote to retain ties with Labour - Guardian

        • US-UK relationship 'rock solid', says Biden during 38-minute Downing St meeting ahead of visit to King - Sky

      • Ireland

        • National property asking price +2.2% y/y, +4.3% q/q; Homes now being sold for 1.4% over asking price versus 5-6% this time last year - MyHome.ie

      • Netherlands

        • Netherlands government collapses; PM Rutte hands in government's resignation; next elections not expected till Nov - euronews

        • Dutch PM Rutte faces no confidence vote after collapse of government - Reuters

      • Sweden

        • Swedish PM Kristersson and Turkey's President Erdoğan to meet in attempt to resolve differences and get Turkey's backing for Sweden's NATO membership - Guardian

        • US, Turkey edge closer to deal on Sweden's NATO membership; bargaining over F-16s - ekathimerini

      • Germany

        • German Defense spending shortfall puts NATO goal in doubt, Ifo Institute says - Bloomberg

      • Spain

        • Pedro Sánchez, the high-stakes gambler, seeks to defy the odds again - Politico

    • Company news:

      • Notable Gainers

        • +95.2% BBED.NA (Beter Bed Holding €5.75, +2.81) -- Torqx Capital Partners intends to acquire Beter Bed Holding for of €6.10/share in cash cum dividend

        • +39.8% NANO.FP (Nanobiotix €6.53, +1.86) -- global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV for NBTXR3

        • +16.3% KGH.LN (Knights Group Holdings £0.74, +0.10) -- FY earnings

        • +6.7% QTX.LN (Quartix Technologies £2.40, +0.15) -- H1 trading update

        • +6.1% FUTR.LN (Future Plc £7.35, +0.42) -- £45M share buyback program

        • +6.0% DRW3.GR (Drägerwerk €46.75, +2.65) -- Warburg Research upgrade

        • +5.6% EAH.LN (Eco Animal Health Group £1.04, +0.05) -- FY earnings

        • +5.1% ALBPS.FP (Biophytis €0.02, -0.00) -- files to initiate SARA-31 phase 3 study of BIO101 in US

        • +5.0% GTT.FP (Gaztransport & Technigaz €96.00, +4.55) -- BNP Paribas Exane upgrade

        • +4.9% EBUS.NA (Ebusco Holding €8.51, +0.40) -- order

        • +4.4% ENTRA.NO (Entra Eiendom NOK99.45, +4.15) -- "

        • +4.3% GPH.LN (Global Ports Holding £2.08, +0.09) -- FY earnings

        • +3.4% SESL.FP (SES-imagotag €120.20, +4.00) -- rejects second part of Gotham City's publication

        • +2.9% TRX.LN (Tissue Regenix Group £0.53, +0.02) -- exclusive distribution agreement for OrthoPure XT in the UK

        • +2.2% ENQ.LN (EnQuest £0.15, -0.00) -- Jefferies upgrade

        • +2.1% RIEN.SW (Rieter Holding CHF91.50, +1.90) -- divestment

        • +2.1% TITC.BB (Titan Cement International €17.54, +0.36) -- resumed buy at Citi

        • +1.9% SCLP.LN (Scancell Holdings £0.13, -0.00) -- pipeline strategy and business update

        • +1.8% NETEL.SS (Netel Holding SEK11.60, +0.20) -- extends framework agreement with Netel in Norway

        • +1.6% SEQUA.BB (Sequana Medical €3.15, +0.05) -- trial update

        • +1.6% BAYN.GR (Bayer AG €49.54, +0.77) -- Bayer preparing to spin off CropScience - Platow Borse

      • Notable Decliners

        • -14.3% AGFX.LN (Argentex Group £1.14, -0.19) -- trading update

        • -10.2% TGS.NO (TGS-NOPEC Geophysical Co. NOK142.30, -16.10) -- prelim Q2 revenue

        • -8.6% ALCOX.FP (Nicox €0.42, -0.04) -- potential annual global net sales for NCX 470 of over $300M

        • -8.1% REVB.LN (Revolution Beauty Group £0.30, -0.03) -- Boohoo to complain to AIM regulatory authorities about Revolution Beauty Group - Sky News

        • -7.8% WIHL.SS (Wihlborgs Fastigheter SEK74.95, -6.30) -- Q2 earnings

        • -7.6% RAIVV.FH (Raisio €1.89, -0.16) -- lowers its 2023 guidance

        • -6.8% DIC.GR (Dic Asset €4.95, -0.36) -- concludes new agreement to extend bridge financing; adjusts forecast for 202

        • -6.8% MMGR.B.SS (Momentum Group SEK109.00, -8.00) -- Danske Bank downgrade

        • -3.7% OTMP.LN (OnTheMarket £0.53, -0.02) -- FY earnings

        • -3.4% VQT.GR (va-Q-tec €25.75, -0.90) -- provides update on va-Q-tec delisting offer

        • -3.2% G24.GR (Scout24 €55.10, -1.80) -- UBS downgrade

        • -2.6% NOEJ.GR (Norma Group €16.00, -0.42) -- Hauck & Aufhäuser downgrade

        • -2.6% HMSO.LN (Hammerson £0.24, -0.01) -- HSBC downgrade

        • -2.4% NACON.FP (Nacon €1.85, -0.05) -- Daedalic Entertainment to be restructured

        • -2.3% SCHP.SW (Schindler Holding CHF198.30, -4.70) -- Goldman Sachs downgrade

        • -1.8% OCDO.LN (Ocado Group £5.82, -0.10) -- Three years required for recovery of Ocado Retail - London Times

        • -1.1% EVK.GR (Evonik Industries €17.55, -0.19) -- Q2 prelim earnigns; lowers FY guidance

    • EU companies reporting tomorrow:

      • Earnings:

        • DACH: Bastei Lübbe (BST.GR), Telekom Austria (TKA.AV)

        • Nordics: Tryg (TRYG.DC), Protector Forsikring (PROT.NO), Nordic Semiconductor (NOD.NO), Aker Carbon Capture (ACC.NO), Kinnevik (KINV.B.SS), XANO Industri (XANO.B.SS), VNV Global (VNV.SS), Investment AB Öresund (ORES.SS)

        • UK: Trifast (TRI.LN), 4t4 Solutions (D4T4.LN)

  • Data:

    • Economics:

      • Denmark

        • May Trade Balance DKK 19.2B vs consensus DKK 29.1B and prior DKK 26.2B

        • Jun CPI +2.5% y/y vs consensus +1.8% and prior +2.9%

      • Norway

        • Jun PPI (28.5%) y/y vs consensus (36.4%) and prior (23.5%)

        • Jun CPI +6.4% y/y vs consensus +6.2% and prior +6.7%

      • Austria May Industrial Production (0.7%) y/y vs consensus (2.7%) and prior +1.0%

      • Eurozone Jul Sentix Investor Confidence (22.5) vs consensus (17.9) and prior (17.0)

      • Greece May Industrial Production +1.4% y/y vs consensus +2.8% and prior revised +4.1% from +4.2%

    • Markets:

      • €-$ +0.0016 or +0.15% to 1.0984

      • £-$ (0.0007) or (0.05%) to 1.2828

      • €-£ +0.0018 to 0.8564

      • S&P 500 +0.12%

      • Performance year-to-date

      • FTSE 100: (2.38%)

      • DAX: +12.45%

      • CAC: +10.35%

      • MIB: +17.51%

      • Stoxx 600: +5.53%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE